Skip to main navigation
Skip to search
Skip to main content
Tampere University Research Portal Home
Help & FAQ
Link opens in a new tab
English
Suomi
Search content at Tampere University Research Portal
Home
Profiles
Research outputs
Research units
Activities
Datasets and software
Research Infrastructures
Press/Media
Prizes
Projects
Pharmacological agents for the prevention of vestibular migraine
Miguel Maldonado Fernández
, Jasminder S. Birdi
, Greg J. Irving
, Louisa Murdin
,
Ilkka Kivekäs
, Michael Strupp
Research output
:
Contribution to journal
›
Review Article
›
peer-review
51
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacological agents for the prevention of vestibular migraine'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacological Agents
100%
Vestibular Migraine
100%
Randomized Controlled Trial
37%
Placebo
37%
Beta-blockers
25%
Anticonvulsant
25%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
25%
Antidepressants
25%
Serotonin Antagonists
25%
Cochrane
25%
Calcium Antagonists
25%
Methodological Procedures
12%
PubMed
12%
Pharmacological Treatment
12%
Literature Search
12%
Preventive Treatment
12%
Early Termination
12%
Web of Science
12%
Positional Vertigo
12%
Issue 5
12%
Metoprolol
12%
International Headache Society
12%
Diagnostic Criteria
12%
International Clinical Trials Registry Platform (ICTRP)
12%
Cochrane Collaboration
12%
Common Cause
12%
CINAHL
12%
Answer Sets
12%
International Headache Society Criteria
12%
Embase
12%
5-HT1
12%
Medicine and Dentistry
Vestibular Migraine
100%
Randomized Controlled Trial
37%
Placebo
37%
Throat Disease
25%
Nose Disease
25%
Headache
25%
Beta Adrenergic Receptor Blocking Agent
25%
Group Trial
25%
Calcium Antagonist
25%
Nonsteroid Antiinflammatory Agent
25%
Anticonvulsant
25%
Serotonin Antagonist
25%
Antidepressant
25%
Metoprolol
12%
Serotonin 1 Agonist
12%
Episodic Vertigo
12%
Pharmacological Treatment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Vestibular Migraine
100%
Randomized Controlled Trial
37%
Placebo
37%
Group Trial
25%
Throat Disease
25%
Antidepressant
25%
Calcium Antagonist
25%
Headache
25%
Beta Adrenergic Receptor Blocking Agent
25%
Anticonvulsive Agent
25%
Non-Steroidal Anti-Inflammatory Drug
25%
Serotonin Antagonist
25%
Nose Disease
25%
Metoprolol
12%
Episodic Vertigo
12%
Serotonin 1 Agonist
12%
Neuroscience
Serotonin Antagonist
25%
Metoprolol
12%